BVS BIOVENTUS INC - A
2026Q1 · CUSIP 09075A108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
155
Δ holders QoQ
+8
Breadth percentile
Top 34%
Whale holders
88
Δ whales
+9
Inst. holding value
$464M
New positions
30
Closed positions
22
Price momentum (1Q)
+26.8%
Put / Call
1/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q3 | Top 7% | -11.0% | -42.1% |
| 2024Q2 | Top 15% | +28.2% | +18.9% |
| 2021Q4 | Top 17% | -29.2% | -31.2% |
| 2021Q3 | Top 14% | -19.2% | -42.8% |
Options Sentiment
Put holders
1
QoQ: +1
Call holders
2
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
28.2
EPS (TTM)
$0.41
EPS YoY
—
Revenue (TTM)
$0.6B
Revenue YoY
+1.5%
Net margin
4.9%
ROE
15.1%
Debt ratio
64.0%
FCF (TTM)
$101M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-28 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.